HemoSense to Present at the Roth Capital Partners 19th Annual Stock Conference.SAN JOSE, Calif. -- HemoSense, Inc. (AMEX AMEX See: American Stock Exchange :HEM) today announced that Jim Merselis, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will make an investment community presentation at the Roth Capital Partners Roth Capital Partners, LLC, is a full service Investment Banking firm, specializing in the small and micro cap markets. Roth’s focus, according to its official website, "has been, is, and will continue to be providing the full spectrum of investment banking services, 19th Annual Stock Conference on Wednesday, February 21 at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the Ritz Carlton in Laguna Niguel, Calif. A live audio and slide webcast of the presentation will be available via the Internet by visiting the Investors section of the Company's Web site at www.hemosense.com. An archived presentation will be available on the Web site for 30 days. About HemoSense HemoSense is a point-of-care diagnostic healthcare company that develops, manufactures and markets easy-to-use, handheld blood coagulation systems for monitoring patients taking warfarin warfarin (wôr`fərĭn), anticoagulant used to treat blood clots. In large doses it causes bleeding. Warfarin, mixed with bait, is used in rodent control. warfarin Anticoagulant drug, marketed as Coumadin. . The HemoSense INRatio[R] system, used by healthcare professionals and patients themselves, consists of a small monitor and disposable test strips. It provides accurate and convenient measurement of blood clotting blood clotting, process by which the blood coagulates to form solid masses, or clots. In minor injuries, small oval bodies called platelets, or thrombocytes, tend to collect and form plugs in blood vessel openings. time, or PT/INR values. Routine measurements of PT/INR are necessary for the safe and effective management of the patient's warfarin dosing. INRatio is sold in the United States and internationally. For more information, visit www.hemosense.com. HemoSense[R] and INRatio[R] are registered trademarks of HemoSense, Inc. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion